Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus

Lancet

Volumn 357, Issue 9264, 2001, Pages 1248-1253

  Pedersen Bjergaard, Ulrik ^a   Agerholm Larsen, Birgit ^b   Pramming, Stig ^c   Hougaard, Philip ^c   Thorsteinsson, Birger ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A;

ADULT; ARTICLE; BLOOD LEVEL; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK;

EID: 0035925892     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04405-6     Document Type: Article

References (27)

1. Hypoglycaemia is the limiting factor in the management of diabetes
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
3. Frequency of severe hypoglycaemia in patients with type 1 diabetes with impaired awareness of hypoglycaemia
4. Human gene for physical performance
5. An insertion/deletion in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
6. ACE gene polymorphism explains 30-40% of variability in serum ACE activity in both women and men in the population at large: The Copenhagen City Heart Study
7. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II): Studies with bradykinin and other natural peptides
8. Elite endurance athletes and the ACE I allel: The role of genes in athletic performance
9. Severe hypoglycaemia in unselected patients with type 1 diabetes: A cross sectional multicentre survey
10. Symptomatic hypoglycaemia in 411 type 1 diabetic patients
11. Hypoglycaemia in the Diabetes Control and Complications Trial
12. Unawareness of hypoglycaemia in insulin-treated diabetic patients: Prevalence and relationship to autonomic neuropathy
13. ACE gene polymorphism: Ischaemic heart disease and longevity in 10 150 individuals: A case-referent and retrospective cohort study based on the Copenhagen City Heart Study
14. Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme
15. Hypoglycaemia associated with use of inhibitors of angiotensin-converting enzyme
16. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoaluminuria or microalbuminuria
17. Hormonal, metabolic and cardiovascular responses to hypoglycaemia in type 1 (insulin-dependent) diabetes with and without residual B cell function
18. Epidemiology of severe hypoglycaemia in the Diabetes Control and Complications Trial
19. Physiological responses to hypoglycaemia: Counterregulation and cognitive function
20. The ACE gene and muscle performance
21. 1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycaemia in humans
22. Participation of angiotensin receptors in acute hypoxia in mice. II. Effects of angiotensin II nonpeptide receptor ligands losartan (DuP-753) and PD-123319
23. The influence of captopril on the epinephrine response to insulin-induced hypoglycaemia in humans: The interactions between the renin-angiotensin system and the sympathetic nervous system
24. Angiotensin II inhibits cortical cholinergic function: Implications for cognition
25. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment
26. ACE insertion/deletion genotype affects bradykinin metabolism
27. Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism